BioSenic Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.12	0.12	1.85	0.76
Cash & Short-Term Investments	0.12	0.12	1.85	0.76
Cash Growth	-84.58%	-93.66%	143.21%	-
Accounts Receivable	0.14	0.14	-	-
Other Receivables	1.32	1.32	2.49	0.36
Receivables	1.46	1.46	2.49	0.36
Other Current Assets	0.27	0.27	0.29	0
Total Current Assets	1.85	1.85	4.63	1.12
Property, Plant & Equipment	0.7	0.7	1.42	0.01
Long-Term Investments	0.01	0.01	0.01	-
Goodwill	-	-	1.8	-
Other Intangible Assets	2.99	2.99	17.29	-
Long-Term Accounts Receivable	0.4	0.4	-	-
Other Long-Term Assets	3.62	3.62	4.17	0.03
Total Assets	9.56	9.56	29.32	1.16
Accounts Payable	3.87	3.87	2.24	0.21
Current Portion of Long-Term Debt	11.82	11.82	8.01	1.25
Current Income Taxes Payable	0.01	0.01	-	-
Other Current Liabilities	0.15	0.15	0.1	0.03
Total Current Liabilities	15.84	15.84	10.35	1.49
Long-Term Debt	16.34	16.34	15.78	2.27
Other Long-Term Liabilities	0.08	0.08	0.07	0.07
Total Liabilities	32.26	32.26	26.2	3.83
Common Stock	6.28	6.28	4.77	0.66
Additional Paid-In Capital	5.72	5.72	4.52	3.97
Retained Earnings	-34.89	-34.89	-5.72	-7.22
Comprensive Income & Other	-0.02	-0.02	-0.04	-0.08
Total Common Equity	-22.91	-22.91	3.53	-2.67
Minority Interest	0.21	0.21	-0.4	-
Shareholders' Equity	-22.71	-22.71	3.12	-2.67
Total Liabilities & Equity	9.56	9.56	29.32	1.16
Total Debt	28.16	28.16	23.79	3.53
Net Cash (Debt)	-28.04	-28.04	-21.95	-2.77
Net Cash Per Share	-0.20	-0.20	-0.14	-41.86
Filing Date Shares Outstanding	149.58	149.58	152.45	0.07
Total Common Shares Outstanding	149.58	149.58	152.45	0.07
Working Capital	-14	-14	-5.73	-0.37
Book Value Per Share	-0.15	-0.15	0.02	-40.40
Tangible Book Value	-25.9	-25.9	-15.57	-2.67
Tangible Book Value Per Share	-0.17	-0.17	-0.10	-40.40

Source: S&P Capital IQ. Standard template. Financial Sources.